Stage A Heart Failure: Modern Strategies for an Effective Prevention

Pompilio Faggiano1, Nicola Bernardi2, Emiliano Calvi2

  • 1Cardiology University of Brescia and Fondazione Poliambulanza, Via 4 Novembre, 7, Brescia 25122, Italy.

Heart Failure Clinics
|March 6, 2021
PubMed

Insights

Early identification of Stage A heart failure (HF) is crucial for individuals at risk. Prompt lifestyle changes and therapeutic interventions can prevent the progression of asymptomatic HF.

Area of Science:

  • Cardiology
  • Preventive Medicine

Background:

  • Stage A heart failure (HF) involves individuals at risk without symptoms or structural heart disease.
  • Cardiovascular risk factors like hypertension, diabetes, and poor lifestyle choices define Stage A HF patients.

Purpose of the Study:

  • To emphasize the importance of early identification of Stage A HF patients.
  • To highlight the need for lifestyle and therapeutic interventions in asymptomatic individuals at risk.
  • To advocate for risk stratification to guide preventive strategies and individualized treatment targets.

Main Methods:

  • Risk factor assessment for cardiovascular diseases.
  • Identification of asymptomatic individuals at risk for heart failure.
  • Stratification of risk profiles for personalized prevention.

Main Results:

  • Asymptomatic individuals with cardiovascular risk factors are identified as Stage A HF.
  • Early intervention is critical for preventing the progression to symptomatic heart failure.
  • Tailored strategies are necessary to manage risk and prevent advanced HF stages.

Conclusions:

  • Early detection and intervention in Stage A HF are vital for long-term cardiovascular health.
  • Personalized risk assessment and management are key to preventing heart failure progression.
  • Addressing modifiable risk factors is essential for individuals at risk of developing heart failure.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
85
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
101
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
236
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
128
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
666
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
119